MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to ...
Clinical-stage biotechnology company, Sensorion (OTC:SENOF) and EVEON, designer and manufacturer of custom medical devices for the preparation and delivery of drugs, collaborate to design and develop ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback